Science, medicine, and the future: Cellular immunotherapy for cancer. - Wikidata - awgldk - TriplyDB

Science, medicine, and the future: Cellular immunotherapy for cancer.

Science, medicine, and the future: Cellular immunotherapy for cancer.

http://www.wikidata.org/entity/Q34455397

about

Trends in cancer immunotherapy Adoptive cellular immunotherapy in metastatic renal cell carcinoma: a systematic review and meta-analysis.Gene therapy for cancer treatment: past, present and future Novel therapeutic agents under investigation for malignant melanoma.Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact.Immunizing effects of cocultures of H22 hepatocarcinoma cells and cartilage polysaccharide on murine H22 hepatocarcinoma.

P2860

Q34052702-9B275C3A-16CA-4907-8826-2D2C9D1D5002 Q34717795-0B633E5E-3957-4D36-943D-4BAA5CDCAB1B Q35040146-AA672971-F034-46A8-A481-EE42FDE1FE79 Q35207632-D665AA9A-24FA-4AE1-8671-2CB074E4B528 Q36403503-8C7DC771-EF1C-4019-9121-2FFED683F320 Q37457750-7FA958D9-E515-44AA-9EB7-9E427401A0E9 Q39550029-A81F1310-B693-410E-8E71-AF9BE13859C4

P2860

Science, medicine, and the future: Cellular immunotherapy for cancer.

http://www.wikidata.org/entity/Q34455397

description

2001 nî lūn-bûn

@nan

2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Science, medicine, and the future: Cellular immunotherapy for cancer.

@ast

Science, medicine, and the future: Cellular immunotherapy for cancer.

@en

Science, medicine, and the future: Cellular immunotherapy for cancer.

@nl

type

label

Science, medicine, and the future: Cellular immunotherapy for cancer.

@ast

Science, medicine, and the future: Cellular immunotherapy for cancer.

@en

Science, medicine, and the future: Cellular immunotherapy for cancer.

@nl

prefLabel

Science, medicine, and the future: Cellular immunotherapy for cancer.

@ast

Science, medicine, and the future: Cellular immunotherapy for cancer.

@en

Science, medicine, and the future: Cellular immunotherapy for cancer.

@nl

P1433

Q34455397-1638258E-A3FE-480A-8C22-DD4C7CC9193C

P1476

Q34455397-CDB9EBD2-0C6D-45B7-A4E7-F4442A3F2B04

P2093

Q34455397-6E970E8A-2E09-4A61-B310-9FEE5589D809

Q34455397-ECDFF797-B1FC-434E-8BC5-19DD46CF85C7

Q34455397-FBA7EF46-D51F-4755-BE9E-94EF3B4D9B19

P2860

Q34455397-1840C265-DD3B-4644-9BED-2196196B48B6

Q34455397-1FFC0219-5890-4B72-BCD0-4459708F467F

Q34455397-26B65322-3942-4048-A7B4-B86EDFD1F8C9

Q34455397-3B229992-DEA9-4CD5-A71C-3672C3E1996A

Q34455397-71BC30DD-79A7-4A0A-93C6-8FB820AD3E4D

Q34455397-A388DA97-4B55-4EBC-9B4F-B37027FC20A5

Q34455397-AA991089-12EF-4527-8A64-48B727D1400E

Q34455397-C80659ED-E190-427E-B7D1-7A967CDCFF78

Q34455397-D4CCB674-A6A0-4B15-8982-FD3EBB02825E

Q34455397-FED5BB9F-A8F3-4832-8682-B9C751272A20

P304

Q34455397-24D32C3A-340D-4614-9893-3A0F19B7DA04

P31

Q34455397-0BFA8DA8-73D6-4F1C-98A7-A2A76FCB65F4

P356

Q34455397-BC45F133-4E51-4F6C-B4AF-1F5C94805C1F

P407

Q34455397-0C74D227-AF34-4915-9147-73F2569302B6

P433

Q34455397-2983E86E-47F1-41CB-ADCB-5C0456F4FB59

P478

Q34455397-E2427F7A-D59A-4F0A-A25F-A33273999927

P577

Q34455397-53FB0D61-61C7-4875-B502-1829D2A1A716

P5875

Q34455397-FD3C56EC-D7F7-44CF-A2FA-961332651C92

P698

Q34455397-E657C634-2E65-470F-9A23-296C7128FDEF

P921

Q34455397-62665CE3-2694-42ED-9A65-2BD8B818D6B4

P932

Q34455397-C8D5EC6A-E1F3-4A74-9DEE-E9E75C075223

P356

BMJ.323.7324.1289

P1433

P1476

Science, medicine, and the future: Cellular immunotherapy for cancer.

@en

P2093

Armstrong AC

http://www.w3.org/2001/XMLSchema#string

Eaton D

http://www.w3.org/2001/XMLSchema#string

Ewing JC

http://www.w3.org/2001/XMLSchema#string

P2860

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.

Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma.

Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors.

Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma.

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia.

Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma.

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1

P304

1289-1293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.323.7324.1289

http://www.w3.org/2001/XMLSchema#string

P407

P433

7324

http://www.w3.org/2001/XMLSchema#string

P478

323

http://www.w3.org/2001/XMLSchema#string

P577

2001-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11625443

http://www.w3.org/2001/XMLSchema#string

P698

11731394

http://www.w3.org/2001/XMLSchema#string

P921

P932

1121751

http://www.w3.org/2001/XMLSchema#string